Human Induced Pluripotent Stem Cells : Clinical Significance and Applications in Neurologic Diseases
- Authors
- Chang, Eun-Ah; Jin, Sung-Won; Nam, Myung-Hyun; Kim, Sang-Dae
- Issue Date
- 9월-2019
- Publisher
- KOREAN NEUROSURGICAL SOC
- Keywords
- Cell-based therapy; Induced pluripotent stem cells; Precision medicine
- Citation
- JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, v.62, no.5, pp.493 - 501
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- JOURNAL OF KOREAN NEUROSURGICAL SOCIETY
- Volume
- 62
- Number
- 5
- Start Page
- 493
- End Page
- 501
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/63412
- DOI
- 10.3340/jkns.2018.0222
- ISSN
- 2005-3711
- Abstract
- The generation of human induced pluripotent stem cells (iPSCs) from somatic cells using gene transfer opens new areas for precision medicine with personalized cell therapy and encourages the discovery of essential platforms for targeted drug development. iPSCs retain the genome of the donor, may regenerate indefinitely, and undergo differentiation into virtually any cell type of interest using a range of published protocols. There has been enormous interest among researchers regarding the application of iPSC technology to regenerative medicine and human disease modeling, in particular, modeling of neurologic diseases using patient-specific iPSCs. For instance, Parkinson's disease, Alzheimer's disease, and spinal cord injuries may be treated with iPSC therapy or replacement tissues obtained from iPSCs. In this review, we discuss the work so far on generation and characterization of iPSCs and focus on recent advances in the use of human iPSCs in clinical setting.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.